Literature DB >> 13278752

The blood-cerebrospinal fluid barrier in tuberculous meningitis and allied conditions.

H V SMITH, L M TAYLOR, G HUNTER.   

Abstract

Entities:  

Keywords:  HEMATO-ENCEPHALIC BARRIER; TUBERCULOSIS, MENINGEAL/physiology

Mesh:

Substances:

Year:  1955        PMID: 13278752      PMCID: PMC503246          DOI: 10.1136/jnnp.18.4.237

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


× No keyword cloud information.
  12 in total

1.  Tuberculous meningitis of acute onset.

Authors:  K B TAYLOR; H V SMITH; R L VOLLUM
Journal:  J Neurol Neurosurg Psychiatry       Date:  1955-08       Impact factor: 10.154

2.  On the bromide test of permeability of the barrier between blood and cerebrospinal fluid--an assessment.

Authors:  G HUNTER; H V SMITH; L M TAYLOR
Journal:  Biochem J       Date:  1954-04       Impact factor: 3.857

3.  The blood-C.S.F. barrier to bromide in diagnosis of tuberculous meningitis.

Authors:  L M TAYLOR; H V SMITH; G HUNTER
Journal:  Lancet       Date:  1954-04-03       Impact factor: 79.321

4.  The results of treatment of 549 cases of tuberculous meningitis.

Authors:  J LORBER
Journal:  Am Rev Tuberc       Date:  1954-01

5.  The intrathecal tuberculin reaction.

Authors:  J SWITHINBANK; H V SMITH; R L VOLLUM
Journal:  J Pathol Bacteriol       Date:  1953-04

6.  Bromide determination in body fluids.

Authors:  G HUNTER
Journal:  Biochem J       Date:  1953-04       Impact factor: 3.857

7.  The action of dehydro-ascorbic acid and alloxan on tuberculin sensitivity in guineapigs.

Authors:  D A LONG; A A MILES; W L M PERRY
Journal:  Lancet       Date:  1951-11-17       Impact factor: 79.321

8.  The chemotherapy of purulent meningitis.

Authors:  H V SMITH
Journal:  Practitioner       Date:  1951-04

9.  Effects of intrathecal tuberculin and streptomycin in tuberculous meningitis; an interim report.

Authors:  H V SMITH; R L VOLLUM
Journal:  Lancet       Date:  1950-08-19       Impact factor: 79.321

10.  The ability of ACTH and cortisone to alter delayed type bacterial hypersensitivity.

Authors:  J B LONG; C B FAVOUR
Journal:  Bull Johns Hopkins Hosp       Date:  1950-09
View more
  10 in total

1.  Invasion of the leptomeninges by tumour: the differential diagnosis from tuberculous meningitis.

Authors:  I E HUGHES; J H ADAMS; R C ILBERT
Journal:  J Neurol Neurosurg Psychiatry       Date:  1963-02       Impact factor: 10.154

2.  The present position regarding the treatment of tuberculous meningitis in children.

Authors:  R I MACKAY
Journal:  Postgrad Med J       Date:  1957-03       Impact factor: 2.401

3.  The entry of radiosodium and of bromide into human cerebrospinal fluid.

Authors:  R B BOURDILLON; M FISCHER-WILLIAMS; H V SMITH; K B TAYLOR
Journal:  J Neurol Neurosurg Psychiatry       Date:  1957-05       Impact factor: 10.154

4.  Abnormal immunological reactions in disseminated sclerosis; a preliminary report.

Authors:  H V SMITH; M L ESPIR; C W WHITTY; W R RUSSELL
Journal:  J Neurol Neurosurg Psychiatry       Date:  1957-02       Impact factor: 10.154

5.  Physiological aspects of the penetration of drugs into the cerebrospinal fluid.

Authors:  H DAVSON; H V SMITH
Journal:  Proc R Soc Med       Date:  1957-11

6.  ANNOTATIONS.

Authors: 
Journal:  Br Med J       Date:  1960-06-11

7.  INTRATHECAL TUBERCULIN IN DISSEMINATED SCLEROSIS: THE IMMUNOLOGICAL ASPECTS.

Authors:  H V Smith; I E Hughes; G Hunter
Journal:  J Neurol Neurosurg Psychiatry       Date:  1961-05       Impact factor: 10.154

8.  Radioactive bromide partition test in differential diagnosis of tuberculous meningitis.

Authors:  B K Mandal; D I Evans; A G Ironside; B R Pullan
Journal:  Br Med J       Date:  1972-11-18

9.  A consideration of the pathogenesis of bacterial meningitis: review of experimental and clinical studies.

Authors:  D H HARTER; R G PETERSDORF
Journal:  Yale J Biol Med       Date:  1960-02

10.  Specific and non-specific immunity in experimental cryptococcosis in mice.

Authors:  D B LOURIA
Journal:  J Exp Med       Date:  1960-05-01       Impact factor: 14.307

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.